ロード中...
Pretherapeutic (68)Ga-PSMA-617 PET may indicate the dosimetry of (177)Lu-PSMA-617 and (177)Lu-EB-PSMA-617 in main organs and tumor lesions
AIM: Combined (68)Ga-PSMA-617 positron emission tomography (PET) imaging and (177)Lu-PSMA-617 therapy is a precise targeted theranostic approach for patients with metastatic castration-resistant prostate cancer (mCRPC). The purpose of this study was to determine whether pretherapeutic standard uptak...
保存先:
| 出版年: | Clin Nucl Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6502681/ https://ncbi.nlm.nih.gov/pubmed/30985422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RLU.0000000000002575 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|